Frontiers in Oncology | Breast Cancer

Original Research

Published on 04 Apr 2025

Differences in treatment response and survival between HER2(2+)/FISH-positive and HER2(3+) breast cancer patients after dual-target neoadjuvant therapy: a matched case-control study

in Breast Cancer

Sicheng Zhou
Xuhui Qin
Wei Xing
Zhao Xu
Chunlv Wei
Yining Ren
Zixing Gong

Frontiers in Oncology

doi 10.3389/fonc.2025.1530793

117 views

Systematic Review

Published on 03 Apr 2025

Predictors of survival among breast cancer patients in Ethiopia: a systematic review and meta-analysis

in Breast Cancer

Chalie Mulugeta
Tadele Emagneneh
Getinet Kumie
Betelhem Ejigu
Abebaw Alamrew

Frontiers in Oncology

doi 10.3389/fonc.2024.1459613

228 views

Original Research

Accepted on 02 Apr 2025

Effect of Fangxia-Dihuang Decoction on Doxorubicin-induced Cognitive Impairment in Breast Cancer Animal Model

in Breast Cancer

Xuan Wang
Qiqi Sun
Li Jianrong
Baoyong Lai
Xiaohua Pei
Nana Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1515498

Original Research

Published on 02 Apr 2025

Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer

in Breast Cancer

Anna R. Schreiber
Stephen G. Smoots
Marilyn M. Jackson
Stacey M. Bagby
Evan D. Dus
Adrian T. A. Dominguez
Cameron A. Binns
Todd M. Pitts
Jennifer R. Diamond

Frontiers in Oncology

doi 10.3389/fonc.2025.1549282

218 views

Systematic Review

Published on 01 Apr 2025

Risk factors for breast cancer recurrence in postmenopausal women: a bibliometric study

in Breast Cancer

Teodora Hoinoiu
Daniel Piţ
Cristina Oprean
Bogdan Hoinoiu
Andra Diaconescu
Ljubisa Grujic
Magda Mihaela Luca
Daciana Grujic

Frontiers in Oncology

doi 10.3389/fonc.2025.1522713

246 views

Systematic Review

Accepted on 31 Mar 2025

The effect of art therapy on quality of life and fatigue in breast cancer patients: a metaanalysis

in Breast Cancer

Yujing Zou
Shanshan Zhai
Jiawen Dong
Tian Yu Zhao
Jin Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1495887

Original Research

Accepted on 31 Mar 2025

Intratumoral and Peritumoral Radiomics Based on Automated Breast Volume Scanner for Predicting Human Epidermal Growth Factor Receptor 2 Status

in Breast Cancer

Hao Zhang
Qing Miao
Yan FU
Ruike Pan
Qing Jin
Changjiang Gu
Xuejun Ni

Frontiers in Oncology

doi 10.3389/fonc.2025.1556317

Case Report

Accepted on 31 Mar 2025

Solid Subtype of Adenoid Cystic Carcinoma of the Breast with Multiple Distant Metastases: A Case Report and Literature Review

in Breast Cancer

Yibo Zhang
Xidie Li
Yaxi Xue
Xiaohui Huang
Fengxian An
Miduo Tan

Frontiers in Oncology

doi 10.3389/fonc.2025.1565175

Case Report

Published on 28 Mar 2025

Symptomatic bone marrow metastasis in triple-negative breast cancer: a case report and literature review

in Breast Cancer

Chenhui Zheng
Jingjing Dai
Yu Wang
Danni Zheng
Renzhi Lin
Zhibao Zheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1570355

294 views

Original Research

Published on 27 Mar 2025

The relationship of depression and quality of life with mediating role of death anxiety, silver lining and religious coping among women cancer patients in Pakistan

in Breast Cancer

Wizra Saeed

Frontiers in Oncology

doi 10.3389/fonc.2025.1489169

235 views

Mini Review

Published on 27 Mar 2025

Diagnostic dilemma of lobular carcinoma: a mini-review of imaging modalities and the role of artificial intelligence and radiomics

in Breast Cancer

Sima Jabbari
Mariam Shadan
Yousef Eltayeb
Omer El Faroug Salim
Nimrah Afaq
Rushda Haider
Sana Sohail Shaikh

Frontiers in Oncology

doi 10.3389/fonc.2025.1515037

1,137 views

Review

Published on 27 Mar 2025

Obesity, overweight and breast cancer: new clinical data and implications for practice

in Breast Cancer

Laura García-Estévez
Marta González-Rodríguez
Isabel Calvo
Alberto Orta
María Gión
Gema Moreno-Bueno
José Manuel Pérez-García
Javier Cortés

Frontiers in Oncology

doi 10.3389/fonc.2025.1579876

260 views

Original Research

Published on 26 Mar 2025

Potent estrogen receptor β agonists with inhibitory activity in vitro, fail to suppress xenografts of endocrine-resistant cyclin-dependent kinase 4/6 inhibitor-resistant breast cancer cells

in Breast Cancer

Lynn M. Marcho
Christopher C. Coss
Menglin Xu
Jharna Datta
Jasmine M. Manouchehri
Mathew A. Cherian

Frontiers in Oncology

doi 10.3389/fonc.2025.1441896

372 views

Original Research

Published on 25 Mar 2025

Advantages of time-dependent diffusion MRI for quantitative microstructural mapping in breast tumors

in Breast Cancer

Lei Bao
Sijie Li
Zhuo Wang
Yang Sun
Ying Qiu
Zhiwei Shen
Xiaoxiao Zhang
Xue Chen
Xiaoxiao Zhang
Junyu Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1537529

326 views

Original Research

Accepted on 24 Mar 2025

Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer

in Breast Cancer

Yongxia Li
Yong Li
Taolang Li
Mingyuan He
Jianying Chang
Hui Cao
Daiqin Luo
Junyuan Lv
Yunbi Zou
Yuyan Zheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1527277

Original Research

Accepted on 24 Mar 2025

A prediction model for predicting relapsed-free survival of earlystage invasive breast cancer patients with hormone receptor positive based on Ki67, HER2 and TOP2A

in Breast Cancer

Dawei Yuan
Rulan Ma
Haixia Ye
Wenbo Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1552937